Navigation Links
Fougera First-to-Market With Calcipotriene Topical Solution 0.005% (Rx) (Scalp Solution)
Date:5/6/2008

MELVILLE, N.Y., May 6 /PRNewswire/ -- Today, Fougera, a division of Nycomed US Inc., announced it has received FDA approval to bring to market the first generic Calcipotriene Topical Solution 0.005% (Rx) (Scalp Solution). The generic formulation compares to Dovonex(R) by Warner-Chilcott.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080506/NYTU034 )

Fougera's Calcipotriene Topical Solution is indicated for the topical treatment of chronic, moderately severe psoriasis of the scalp (see product package insert for full prescribing information). It is available in a 60 mL bottle (NDC # 0168-0400-60).

"Fougera has received more FDA approvals for topical products during the past seven years than any other generic company. Today's announcement that we are first-to-market with Calcipotriene Topical Solution is another example of our ongoing commitment to provide safe, effective and affordable options to health care providers and their patients," stated David Klaum, Senior Vice President, Commercial Business Operations.

Founded in 1849, Fougera is the largest of the three Nycomed US Inc. divisions and is the leading manufacturer and distributor of a wide range of topical steroids, antibiotics and antifungal products. For more information on Fougera's complete line of products, please call Fougera Customer Service at (800) 645-9833 or visit the company online at http://www.fougera.com.

About Nycomed US

Nycomed US, Inc. (formerly ALTANA Inc) is a subsidiary of Nycomed, and also operates two additional divisions in the US focused on specialty pharmaceuticals in dermatology. The PharmaDerm(R) division of Nycomed is dedicated to bringing innovative products to the dermatologists so they can best care for their patients. Nycomed US, Inc. and its PharmaDerm Division recently announced the acquisition of Bradley Pharmaceuticals, a global specialty company with 3 divisions-Doak Dermatologics, Kenwood Therapeutics, and A. Aarons. The Bradley product line will be combined with the current offerings of PharmaDerm, enabling the Company to offer more therapeutic choices and enhanced customer service. Combined with Nycomed's Fougera Division, Nycomed becomes a leader in the dermatology market. Nycomed US also markets and sells Savage Laboratories products, which focus on emergency care.


'/>"/>
SOURCE Fougera
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ImQuest Presents New Anti-HIV Drug and Topical Microbicide Development Results on Lead Pyrimidinedione Products IQP-0410 and IQP-0528
2. Topical Cream Treats Precancerous Lesions of Vulva
3. ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic
4. International Federation of Sports Medicine Selects Celadrin(R) Topical Cream as its First and Only Official Joint and Muscle Topical Cream
5. Summit VetPharm Introduces New Feline Topicals Vectra(TM) for Cats & Kittens and Vectra(TM) for Cats
6. Topical treatment for age spots, from Harvard Womens Health Watch
7. Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction
8. Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis
9. Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
10. Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
11. UHW Outlines Solutions to Californias Health Crisis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... Utah (PRWEB) , ... May 06, 2016 , ... ... Step, an online provider of career-focused education and corporate training, and the National ... are pleased to announce Maritza Aquino as the second full-tuition scholarship recipient of ...
(Date:5/5/2016)... ... 2016 , ... TransWipe Volume 3 is a set of 30 professional transition ... preset between two video clips to instantly add a unique transition to any Final ... color and orientation options. TransWipe Volume 3 is a Final Cut Pro X exclusive ...
(Date:5/5/2016)... ... May 05, 2016 , ... The ... electronic cigarettes, requiring e-cigarette manufacturers to submit their products through an arduous federal ... all vaping products that entered the market since February 15, 2007. That would ...
(Date:5/5/2016)... SAN FRANCISCO (PRWEB) , ... May 05, 2016 ... ... in the Unites States to promise successful results with IVF and with egg ... Designed to deliver the most patient-centric and highest quality fertility care, Spring Fertility ...
(Date:5/5/2016)... ... ... Derrin Doty Group has unveiled the latest charity campaign in their ongoing ... Seattle. The insurance provider’s caring team has been so moved by the sudden death ... from the flu, that they have decided to extend their original campaign. Compassionate community ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... May 4, 2016 According to market ... and Demand Forecast to 2022 - Industry Insights by Slice ... Center and Others)" by P&S Market Research, the global ... 2015, and it is expected to grow at a CAGR ... slice type segment is expected to witness the faster growth, ...
(Date:5/4/2016)... D.C. , May 4, 2016 ... member companies concluded a series of free workshops ... in global requirements for Good Distribution ... of quality assurance which ensures that products are consistently stored, ... the marketing authorization (MA) or product specification. Only a ...
(Date:5/4/2016)... May 4, 2016 ... the  "Global Multiple Myeloma Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... and Competitive Landscape Highlights 2016, provides comprehensive ... Myeloma epidemiology, Multiple Myeloma market valuations and ...
Breaking Medicine Technology: